<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4757">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01772602</url>
  </required_header>
  <id_info>
    <org_study_id>CDC-NCEH/ATSDR-5768</org_study_id>
    <nct_id>NCT01772602</nct_id>
  </id_info>
  <brief_title>The National Amyotrophic Lateral Sclerosis Registry</brief_title>
  <official_title>The National Amyotrophic Lateral Sclerosis Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centers for Disease Control and Prevention</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Department of Veterans Affairs</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centers for Medicare and Medicaid Services</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>Centers for Disease Control and Prevention</source>
  <oversight_info>
    <authority>United States: Federal Government</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this registry is to (A) better describe the incidence and prevalence of
      Amyotrophic Lateral Sclerosis (ALS) in the United States;(B) examine appropriate factors,
      such as environmental and occupational, that may be associated with the disease; (C) better
      outline key demographic factors (such as age, race or ethnicity, gender, and family history
      of individuals who are diagnosed with the disease) associated with the disease; and (D)
      better examine the connection between ALS and other motor neuron disorders that can be
      confused with ALS, misdiagnosed as ALS, and in some cases progress to ALS.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>N/A</study_design>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>The National Amyotrophic Lateral Sclerosis (ALS) Registry</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>To determine the incidence and prevalence of Amyotrophic Lateral Sclerosis in the US.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Risk factors of ALS</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>To learn more about the potential risk factors for ALS</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Amyotrophic Lateral Sclerosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        ALS cases in the United States
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - U.S. citizens 18 years of age or older

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Mehta, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centers for Disease Control and Prevention</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paul Mehta, MD</last_name>
    <phone>770-488-0556</phone>
    <email>PMehta1@cdc.gov</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kevin Horton, DrPH, MSPH</last_name>
    <phone>770-488-1555</phone>
    <email>dhorton@cdc.gov</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CDC</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30333</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Mehta, MD</last_name>
      <phone>770-488-0556</phone>
      <email>PMehta1@cdc.gov</email>
    </contact>
    <contact_backup>
      <last_name>Kevin Horton, DrPH, MSPH</last_name>
      <phone>770-488-1555</phone>
      <email>dhorton@cdc.gov</email>
    </contact_backup>
    <investigator>
      <last_name>Paul Mehta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.cdc.gov/als</url>
    <description>Click here to enroll in the National ALS Registry</description>
  </link>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 30, 2013</lastchanged_date>
  <firstreceived_date>January 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Amyotrophic Lateral Sclerosis</keyword>
  <keyword>Lou Gehrig's Disease</keyword>
  <keyword>Motor Neuron Disease</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Motor Neuron Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
